Barclays analyst Benjamin Budish maintained a Buy rating on KKR & Co (KKR – Research Report) today and set a price target of $129.00. The ...

KKR Income Opportunities Fund offers a high-yield through a diversified portfolio of lower-quality investments managed by ...

KKR is closing in on a $2.9B takeover of Karo Healthcare after outbidding rivals, reinforcing its aggressive push into ...

Shares of KKR & Co. Inc. KKR climbed 16.88% to $110.46 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 9.52% to 5,456.90 and ...

(Reuters) -British medical property owner REIT Assura has agreed to a 1.61 billion pound ($2.06 billion) takeover bid from ...

A deal would be counter to the downbeat mood following Donald Trump's decision to place tariffs on almost every country ...